SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-05-022461
Filing Date
2005-04-27
Accepted
2005-04-27 18:16:59
Documents
2
Period of Report
2005-04-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4872
2 POA DOCUMENT poa.txt EX-24.4_82734 2867
  Complete submission text file 0001209191-05-022461.txt   9554
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address C/O LA JOLLA PHARMACEUTICAL CO 6455 NANCY RIDGE DRIVE SAN DIEGO CA 92121 8586466649
ENGLE STEVEN B (Reporting) CIK: 0001234368 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24274 | Film No.: 05777690